Viewing nowKukje Rozaartan 50 mg (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

MFDS item code 200500391 · Notified 2005.05.24 · Insurance code 643700150
Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension
This medication is used to treat hypertension, and it also helps prevent and treat kidney disease in patients with type 2 diabetes, particularly those with hypertension. It is useful for effectively managing high blood pressure to protect heart and kidney health.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time every day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium administered orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be administered orally in 2 divided doses daily, or, if necessary, the dose may be increased to 100 mg once daily. 3) If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed when it is administered in combination with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with insulin and commonly used blood glucose-lowering agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Elderly patients No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger; for elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with decreased effective circulating blood volume For patients who may have decreased effective circulating blood volume (intravascular volume depletion) (e.g., patients receiving diuretic therapy), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). 4) Patients with hepatic impairment A lower dose should be considered for patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
2) Pediatric patients and adolescents aged 6 years and older (1) Patients weighing at least 20 kg but less than 50 kg who can swallow tablets: The recommended dose is 25 mg of this drug once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. (2) Patients weighing 50 kg or more: The usual recommended dose is 50 mg of this drug once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. (3) Pediatric patients under 6 years of age: Not recommended. (3) Pediatric patients with a glomerular filtration rate of less than 30 mL/min/1.73㎡: Not recommended. (3) Pediatric patients with hepatic impairment: Not recommended.
This drug can cause serious harm to the fetus if taken during the second and third trimesters of pregnancy, so use should be discontinued immediately if pregnancy is confirmed. It is safest for women who may become pregnant to avoid taking this medication, and it is advised that pregnant women refrain from use for the health of the fetus. This medication should not be administered to patients with certain conditions, such as severe liver impairment, hereditary angioedema, or primary hyperaldosteronism. Patients with genetic issues such as lactose intolerance should also avoid this medication. Elderly patients, those with hyperkalemia, mild to moderate liver impairment, or valvular heart disease should use this drug cautiously, considering the risk of heart and cerebrovascular issues due to blood pressure reduction. As this medication lowers blood pressure, special care is required for patients with reduced intravascular blood volume or severely impaired kidney function. While taking this medication, various adverse reactions may occur, with common symptoms including dizziness, muscle cramps, back pain, cough, and indigestion. Rarely, serious side effects such as angioedema or liver dysfunction, and rhabdomyolysis may occur, so immediate consultation with a physician is necessary if abnormal symptoms appear. The risk of side effects like hyperkalemia may increase when this medication is taken in conjunction with other antihypertensives or potassium-sparing diuretics, so caution is advised with co-administration. Potassium supplements or salt substitutes containing potassium should not be taken without consulting a physician. Regular monitoring of blood pressure, kidney function, and electrolyte levels during treatment is important to check for abnormalities. This medication is not recommended for breastfeeding women, and breastfeeding should be discontinued if necessary. In case of overdose, hypotension and tachycardia may occur, and prompt treatment in a hospital setting is required. Finally, this medication should be kept out of reach of children and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is also advisable to keep it in a cool, dry place, maintaining a temperature between 15 and 30 degrees Celsius.
White oval film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Withus Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.